Skip to Content

Medications for Acute Myeloid Leukemia

Other names: Acute Granulocytic Leukemia; Acute Myelogenous Leukemia; AML; ANLL; Cancer, Acute Granulocytic Leukemia; Cancer, Acute Myelogenous Leukemia; Cancer, Acute Myeloid Leukemia; Leukemia, Acute Granulocytic; Leukemia, Acute Myelogenous; Leukemia, Acute Myeloid

What is Acute Myeloid Leukemia:  Acute myeloid leukemia (AML) is cancer that starts inside bone marrow, the soft tissue inside bones that helps form blood cells. The cancer grows from cells that would normally turn into white blood cells.

Medications to treat Acute Myeloid Leukemia

The following list of medications are in some way related to, or used in the treatment of this condition.

Drug name Rx / OTC Pregnancy CSA Alcohol Reviews Rating Popularity
cytarabine D N Add review Rate

Generic name: cytarabine systemic

Drug class: antimetabolites

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

 
Oncovin D N Add review Rate

Generic name: vincristine systemic

Drug class: mitotic inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph

 
daunorubicin D N Add review Rate

Generic name: daunorubicin systemic

Brand name:  Cerubidine

Drug class: antibiotics/antineoplastics

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

 
vincristine D N Add review Rate

Generic name: vincristine systemic

Brand names:  Oncovin, Vincasar PFS

Drug class: mitotic inhibitors

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

 
Cerubidine D N Add review Rate

Generic name: daunorubicin systemic

Drug class: antibiotics/antineoplastics

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
Vincasar PFS D N Add review Rate

Generic name: vincristine systemic

Drug class: mitotic inhibitors

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
idarubicin D N Add review Rate

Generic name: idarubicin systemic

Brand names:  Idamycin, Idamycin PFS

Drug class: antibiotics/antineoplastics

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

 
Mylotarg D N Add review Rate

Generic name: gemtuzumab systemic

Drug class: CD33 monoclonal antibodies

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
decitabine Off Label D N Add review Rate

Generic name: decitabine systemic

Drug class: antimetabolites

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

Off Label: Yes

 
enasidenib U Add review Rate

Generic name: enasidenib systemic

Brand name:  Idhifa

Drug class: miscellaneous antineoplastics

For consumers: interactions, side effects

 
Idamycin D N Add review Rate

Generic name: idarubicin systemic

Drug class: antibiotics/antineoplastics

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
Idamycin PFS D N Add review Rate

Generic name: idarubicin systemic

Drug class: antibiotics/antineoplastics

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
Idhifa U Add review Rate

Generic name: enasidenib systemic

Drug class: miscellaneous antineoplastics

For consumers: interactions, side effects

For professionals: Prescribing Information

 
midostaurin N Add review Rate

Generic name: midostaurin systemic

Brand name:  Rydapt

Drug class: multikinase inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph

 
Rydapt N Add review Rate

Generic name: midostaurin systemic

Drug class: multikinase inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
cytarabine liposomal / daunorubicin liposomal U Add review Rate

Generic name: cytarabine liposomal / daunorubicin liposomal systemic

Brand name:  Vyxeos

Drug class: antineoplastic combinations

For consumers: interactions, side effects

 
Vyxeos U Add review Rate

Generic name: cytarabine liposomal / daunorubicin liposomal systemic

Drug class: antineoplastic combinations

For consumers: interactions, side effects

For professionals: Prescribing Information

 

Topics under Acute Myeloid Leukemia

Learn more about Acute Myeloid Leukemia

Legend

Off Label This medication may not be approved by the FDA for the treatment of this condition.
Prescription Only / Over the Counter
Rx Prescription Only
OTC Over the Counter
Rx/OTC Prescription or Over the Counter
Pregnancy
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act Schedule
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Browse Drugs by Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Hide